CHANGES IN THE QUALITY OF LIFE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AFTER THE USE OF BIOREGULATORY DRUGS

Хамраев Фарид Хамидуллаевич, Исмаилов Джамшид Абдураимович, Расули Фарида Орифовна, Хамидуллаев Фирдавс Фаридович, Камалов Анвар Ибрагимович

Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali · 2024-yil

Annotatsiya

The quality of life (QOL) of patients with chronic obstructive pulmonary disease is currently one of the main indicators for assessing the effectiveness of therapy. This indicator is directly related to health, is one of the key concepts of modern medicine and allows us to carry out an in-depth analysis of important components of human health in accordance with WHO criteria. All patients (168 patients with COPD, 90 of whom had ischaemic heart disease) were divided into 2 groups: the main group (60 patients) received baseline therapy and bioregulatory drugs, and the control group (108 patients) received only baseline therapy. QOL was assessed using the SF-36 questionnaire.

Maqola ma’lumotlari
MualliflarХамраев Фарид Хамидуллаевич, Исмаилов Джамшид Абдураимович, Расули Фарида Орифовна, Хамидуллаев Фирдавс Фаридович, Камалов Анвар Ибрагимович
JurnalJournal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali
Nashr sanasi2024-02-01
Jild4
Son4
TilIngliz

Kalit so‘zlar

хроническая обструктивная болезнь легких, воспаление, качество жизни, биорегуляторные препараты, chronic obstructive pulmonary disease, inflammation, quality of life, bioregulatory drugs., surunkali obstruktiv o'pka kasalligi, yallig'lanish, hayot sifati, bioregulyator dorilar.

Ilmiy soha

Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali jurnalidan boshqa maqolalar

Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali — barcha maqolalar